You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RYTM Sale Disclosure
Smith Hunter C · SEC Form 4 · Filed Sep 1, 2026
Sale
Calculated transaction value
$1.21M
Smith Hunter C Chief Financial Officer
RYTM
Transaction date
Aug 31, 2026
Public filing date
Sep 1, 2026
Filing lag
Filed 1 day later
RYTM daily price context
Close on/before transaction
$106.13
Aug 31, 2026
First close after public filing
$105.42
Sep 2, 2026
30-day return after filing
-11.39%
Through Oct 1, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 11,514 shares @ $105.37
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001649904-26-000023
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$8.09M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. RYTM Current | Sale | Aug 31, 2026 | $1.21M |
| Rhythm Pharmaceuticals, Inc. RYTM | Sale | Aug 31, 2026 | $2.41M |
| Rhythm Pharmaceuticals, Inc. RYTM | Sale | Aug 31, 2026 | $2.99M |
| Rhythm Pharmaceuticals, Inc. RYTM | Exercise | Aug 31, 2026 | $0 |
| Rhythm Pharmaceuticals, Inc. RYTM | Exercise | Aug 31, 2026 | $1.47M |